
Color Vision and Microperimetry Changes in Nonexudative Age-Related Macular Degeneration After Risuteganib Treatment: Exploratory Endpoints in a Multicenter Phase 2a Double-Masked, Randomized, Sham-Controlled, Crossover Clinical Trial
Author(s) -
Eleonora M. Lad,
David S. Boyer,
Jeffrey S. Heier,
Julie Kornfield,
Baruch D. Kuppermann,
Hugo Quiróz-Mercado,
Janine Aubel,
Lisa Karageozian,
Hampar Karageozian,
Melvin Sarayba,
Vicken Karageozian,
Peter Kaiser
Publication year - 2022
Publication title -
ophthalmic surgery, lasers and imaging retina
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.676
H-Index - 30
eISSN - 2325-8179
pISSN - 2325-8160
DOI - 10.3928/23258160-20220725-02
Subject(s) - microperimetry , macular degeneration , medicine , ophthalmology , drusen , visual acuity , randomized controlled trial , mesopic vision , crossover study , clinical endpoint , surgery , retinal , photopic vision , pathology , placebo , alternative medicine